Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,589 shares of the medical equipment provider’s stock after selling 32 shares during the period. Douglass Winthrop Advisors LLC’s holdings in Intuitive Surgical were worth $1,272,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Mirador Capital Partners LP raised its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares during the last quarter. Consolidated Planning Corp raised its stake in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after acquiring an additional 76,649 shares during the period. Swiss National Bank grew its stake in shares of Intuitive Surgical by 0.3% in the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after purchasing an additional 3,400 shares in the last quarter. Finally, ABLE Financial Group LLC acquired a new position in shares of Intuitive Surgical during the third quarter valued at $604,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,539 shares of company stock valued at $26,112,364. Corporate insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Robert W. Baird increased their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup boosted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Truist Financial upped their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Stock Down 0.5 %

Shares of Intuitive Surgical stock opened at $547.87 on Monday. The stock has a market cap of $195.14 billion, a PE ratio of 88.08, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The business has a fifty day simple moving average of $504.73 and a 200-day simple moving average of $464.13.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.